PACS Group, Inc. (PACS) stock
PACSNYSEServices-Skilled Nursing Care FacilitiesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 12/3023% above fair value
$48.55−0.45 (-0.92%)
Close on Nov 17, 2026Market cap $7.69BP/E 27.7Yield –
PACS r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for PACS
PACS has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?